Google Cloud PlatformGCPGoogle CloudLeadershipCollaboration
About this role
Role Overview
Develop and execute the global clinical affairs strategy aligned to pipeline and growth objectives
Build integrated evidence-generation plans supporting FDA, IVDR, CE Mark, and international submissions
Serve as a trusted executive advisor on clinical trends, competitive dynamics, and market opportunities
Translate unmet customer needs from health systems, laboratories, and clinicians into actionable clinical priorities
Lead multicenter pivotal trials, performance studies, usability studies, and post-market evidence programs
Ensure high-quality execution across timelines, budgets, CRO management, and investigator relationships
Interpret clinical data to support claims development, product positioning, and launch readiness
Advance programs in respiratory disease, sepsis, bloodstream infection, antimicrobial stewardship, and emerging pathogens
Lead evidence strategies for troponin, BNP/NT-proBNP, coagulation, and cardiovascular risk diagnostics
Drive adoption strategies informed by real-world clinical laboratory operations and customer workflow needs
Build relationships with hospital labs, integrated delivery networks, academic centers, and reference laboratories
Collaborate with Medical Affairs to develop and implement publication strategy, advisory boards, and KOL engagement
Support market access and reimbursement evidence needs
Partner with Commercial teams on evidence-based messaging and customer education
Recruit, mentor, and retain top clinical affairs talent
Build scalable processes, metrics, and organizational capability to support growth
Foster a culture of urgency, accountability, collaboration, and excellence
Requirements
PhD preferred with 10-15+ years of progressive leadership experience in Clinical Affairs, Medical Affairs, or Clinical Research within IVD or medical diagnostics
Significant leadership experience within a top-tier diagnostics organization
Demonstrated success leading studies supporting major product launches and regulatory approvals